Updated 08.12.2025

Permits

We issue permits for the secondary use of social and health data, combine data that is subject to a permit securely and pre-process the data ensuring the privacy of citizens.

See the end of the page for frequently asked questions.

Book a time for personal consultation

You can book a time for personal consultation with an expert from Findata. Appointments are available three days a week and last for 20 minutes. The meetings are held remotely via Teams.

We offer help in the following topics:

  • General consultation on Findata’s services
  • Data permit applications, amendments, and data requests
  • Extraction description form and other forms
  • Ordering Findata’s secure processing environment Kapseli, pausing, and data storage service

You can see the available times below.

Make sure you have written your email address correctly. After booking, we will send a confirmation to your email and a downloadable calendar reminder. We will send the link to the Teams meeting later.

If you have not received a confirmation or Teams link, email us at info@findata.fi.

The personal consultation service is provided as a part of the FinHITS project funded by the European Union.

What to remember before sending an application

Select the correct application type

There are different types of applications for different information needs

  • Data permit application, when you need data on individuals
  • Data request, when you need statistical data
  • Amendment application, when you are applying for an amendment to a valid data permit
Describe and limit data

Define the data to be applied for at the variable level and remember the principle of minimisation for other information. Utilise the Data Resources Catalogue (aineistokatalogi.fi) and controller’s advisory services

  • Where from and how do I extract the target group? Is the definition specific enough?
  • Are control subjects/relatives extracted? How will they be defined?
  • From which registers will the data be extracted?
  • What variables will be included in the extraction? 

Other data to be combined

  • Have you made sure that the other data is described on the application?
  • Are the permits for other data valid or is the permit process pending?
Determine the competent authority

We grant permits for the secondary use of social and health data when the application applies to

  • data maintained by several public social and health sector controllers
  • data maintained by a single public controller, that has transferred the right to issue permits to Findata
  • the register data of one or numerous private social and health service provider, or
  • data saved in the Kanta Services

The assessment of the competent authority must consider all the data related to the application.

Check from the application assistant which authority the application should be sent to.

Are you new to the Finnish health data landscape?

Start your application journey with our training that introduces how Finland’s healthcare system is organised and presents key health data registers available for secondary use, such as Kanta, the Care Register, and FinRegistry ready-made dataset. Begin training Are you new to the Finnish health data landscape?

Before applying

What data use can permits be issued for?

A permit can be issued for the purposes laid down in law, which are listed below. Data on individuals will be sent to a secure operating environment for analysis, while statistical data can be sent to the applicant.

According to the Act on the Secondary Use of Health and Social Data (Secondary Use Act), data can be used without a separate permit also for knowledge management and steering and supervision of social and health care by authorities.

Individual-level material

  • scientific research
  • statistics
  • education
  • planning and reporting duty of an authority

In addition, under the Secondary Use Act, controllers can use their own data for knowledge management without a permit from Findata.

Statistical data

  • scientific research
  • statistics
  • planning and reporting duty of an authority
  • steering and supervision of social and health care by authorities
  • education
  • development and innovation activities
  • knowledge management (comparative data)

As a rule, the Secondary Use Act applies to register-based studies. A register-based study utilises register data usually collected for other purposes or national registers. The Secondary Use Act does not apply to clinical trials reported to the Finnish Medicines Agency (Fimea) or to medical trials under the Medical Research Act.

What data does Findata grant permits for?

We grant permits for data from social and health sector controllers. In addition, we grant permits to our ready-made datasets which are pre-compiled and pre-processed datasets on specific themes.

Note that we cannot issue permits for data from all controllers covered by the Secondary Use Act. Details on these data restrictions can be found in the Secondary Use Act.

View controllers under the Secondary Use Act
  • Digital and Population Data Services Agency
    • Individual’s basic details, family relations, place of domicile and building details
  • Findata
  • Finnish Centre for Pensions
    • Work and earnings data, benefits and the bases for them
  • Finnish Institute for Health and Welfare
    • Does not apply to data collected for statistical purposes
  • Finnish Institute of Occupational Health
    • Occupational illnesses, exposure tests and patient registers
  • Finnish Medicines Agency Fimea
  • Kanta services
  • National Supervisory Authority for Welfare and Health Valvira
  • Public and private service providers of social welfare and health care
  • Regional state administrative agencies
    • Matters relating to social welfare and health care
  • Social Insurance Institution of Finland
    • Benefits and prescriptions
  • Statistics Finland
    • To the extent that access is required to data covered by the act on the investigation of the causes of death

See details on available data

Use our Data assistant to find out which data controllers and registries hold the data you are interested in.

Read more:

Data descriptions and additional information

Data controllers provide advisory services for their own data. They are the best source for detailed information on their data variables. Descriptions of some of the data within the scope of the Secondary Use Act can be found in the Data Resources Catalogue.

You can arrange with the controller to implement data extraction in a specific manner. In your application to us, specify the contact person with whom you made this arrangement.

Read more:

When do I submit an application to Findata?

Submit your data permit or amendment permit application to Findata if you want to apply for:

  • Data from several public social and health sector controllers covered by the Secondary Use Act.
  • Data from a single public controller that has transferred the right to issue permits to Findata (see the list).
  • Data from one or more private social welfare and health care service organisers.
  • Customer data saved in the Kanta Services.
  • Findata’s ready-made dataset.

If you need statistical aggregated data, send data request to Findata.

Unsure where to send your application? Use Application Assistant!

Public sector social and health controllers are divided into two groups under the Secondary Use Act, each with different competences. The following section explains these groups and their roles.

Public sector controllers: Group 1

  • Finnish Institute of Occupational Health (TTL)
  • Regional State Administrative Agencies (AVI)
  • Social Insurance Institution (Kela)
  • Finnish Medicines Agency (Fimea)
  • National Supervisory Authority for Welfare and Health (Valvira)
  • Public service providers of social welfare and health care
  • Ministry of Social Affairs and Health (STM)
  • Finnish Institute for Health and Welfare (THL)

Findata is responsible for issuing data and amendment permits when the application involves data from at least two controllers in this group.

This includes cases where the applicant wants to combine their own register data with data from other controllers. For example, if a wellbeing services county needs data from both Kela and its own data, Findata grants the permit.

If the application or data utilisation plan includes combining data from this group with data from other sources, Findata grants the permit.

Findata does not grant permits for clinical trial data reported to Fimea.

Public sector controllers: Group 2

  • Digital and Population Data Services Agency (DVV): Basic personal data, family relations, place of residence, and building details.
  • Finnish Centre for Pensions (ETK): Employment and income data, benefits, and disability pension diagnoses.
  • Statistics Finland: Information for determining cause of death.

Findata is responsible for issuing data and amendment permits when the application involves data from DVV and ETK and the application also conserns:

  • Data from controllers in Group 1.
  • Data from private social welfare and health care service organisers.
  • Data saved in the Kanta Services.

If the application involves data from Statistics Finland and more than one other controller, Findata grants the permit.

Statistics Finland will process the application if it concerns only their data on causes of death and data from only one of the controllers covered by the Secondary Use Act.

The Secondary Use Act does not cover clinical trials reported to Fimea, so these are outside Findata’s scope. Definitions for interventional clinical trial and noninterventional study are available in Fimea Regulation 8/2019. Fimea can advise if a study is considered a clinical trial.

Applying

All applications to Findata are sent in our e-service with an online form. Log into the service using Suomi.fi e-Identification or Haka log in.

Please use the same identification method each time you log in to view your submitted applications and decisions. For more information on logging in see the Login page

Dates of monthly maintenance outages in 2025

Monthly maintenance on Findata’s services occurs on the Thursday after the second Tuesday of each month, from 8 a.m. to 12 p.m. (EEST), following Microsoft’s Windows update schedule.

  • 23 January 2025
  • 20 February 2025
  • 20 March 2025
  • 17 April 2025
  • 22 May 2025
  • 19 June 2025
  • 17 July 2025
  • 21 August 2025
  • 18 September 2025
  • 23 October 2025
  • 20 November 2025
  • 18 December 2025
Restrictions

You can log in using Suomi.fi authentication or Haka login. If neither method is available to you, please request an identification form by emailing info@findata.fi.

Data permit, data permit amendment and data request application forms have been updated several times. Unfortunately it is not possible to copy old application versions as new ones. We kindly ask you to fill in a new application form.

Selecting and completing an application form

Choose the application form based on your needs:

  • Data permit: Use this form when you need individual-level data. Analysis of this data will occur in audited, secure processing environment.
  • Data request: Use this form when you need statistical data. The statistical data will be sent to you directly.
  • Amendment permit: Use this form to request changes to an existing data permit.

Complete the application form carefully. Incomplete applications will be returned to the applicant with a request for additional information.

If you’re unsure which application to choose or what information to enter into a field on the form, seek help well in advance from within your organisation or contact our advisory service at info@findata.fi.

How to expedite the processing of your application

The processing time for applications depends on several factors: the accuracy of the data extraction description, the current backlog at Findata, and the response times of data controllers.

By following the following guidelines, you can help ensure that your application is processed as quickly and efficiently as possible.

  1. Verify Findata’s authority:
    • Ensure Findata is the competent authority to issue a permit for the data you need.
    • Use the application assistant to help determine this.
    • Note that the Digital and Population Data Services Agency, the Finnish Centre for Pensions, and Statistics Finland handle their own data and permit decisions. If you need information from these controllers, contact them directly.
  2. Consult Findata’s help desk:
    • If unsure about where to send your application, contact Findata’s help desk service at info@findata.fi before submitting it.
  3. Contact data controllers directly:
    • If you need more information about the data or variables, contact the relevant data controllers. Data controllers provide advisory services for their data and can guide you on data extraction methods. You can also make an agreement on the implementation of data extraction in a certain manner with the controller.
    • In your application, mention the contact person with whom you have discussed the data extraction.
    • See information and contact details for controllers: Links to data controllers’ websites and data descriptions
  4. Use the Data Resources Catalogue:
  5. Describe your information needs accurately:
    • Clearly define the information needed and specify the register-specific data extractions in your application.
    • If the extraction involves multiple steps, describe the order of extraction using the extraction description form (download Word file, 51.2 kb).
    • Ensure that the data extractions and the data you request are essential and justified.
  6. Apply the GDPR minimisation principle:
    • Only request data that is essential for your purposes. The principle of minimisation as defined in the GDPR will be applied, meaning that only necessary data will be disclosed.
  7. Complete the application carefully:
    • Pay attention to entering basic data such as the applicant’s details, the data controller, invoicing details, and any other data to be combined.

 If you need to supplement a submitted application, email us at info@findata.fi. In the subject line, write “Return of application” followed by your application’s diary number (e.g., “Return of application THL/XXXX/14.0X.00/202X”).

See also:

Tips for defining the extraction of textual data
  1. Consider necessity: Determine if textual data is essential for conducting your research.
    • The need for unstructured data must always be justified. Often, similar information can be extracted in a structured format.
    • We mask direct identifiers in textual data, which affects the usability of the data.
    • Processing textual data takes time and significantly increases costs.
  2. Request insights from the data controller on appropriate keywords.
    • The data controller is best positioned to assess which keywords will yield the most comprehensive results without extraneous information.
    • For example, the keyword pressure will produce all records related to pressure, such as blood pressure, eye pressure, etc. If the research focus is on blood pressure, the extracted textual data will contain a substantial amount of unnecessary information.
  3. Specify the length of the text snippet to be extracted on a variable-by-variable basis.
    • The text snippet should be as short as possible.
    • Request the data controller’s view on the length of the text to be extracted.
      • For instance, keyword +/- 50 characters.
  4. Ensure the extraction is scoped appropriately.
    • If the extraction can be limited to the information from a specific department or field of treatment instead of the entire healthcare district’s database, the amount of text to be extracted and the processing costs will be significantly lower.

Transfer of personal data outside the EU/EEA

The processing of personal data from abroad is, by default, considered a transfer of personal data, even if the data is in a remote access environment.

The affiliation of the data processor with the data controller may affect this assessment. If the data processor is employed by a data controller located within the EU/EEA, processing from abroad is not considered a data transfer, and the processor may access the data from outside the EU/EEA.

Example: Transfer of personal data outside the EU/EEA

  • Findata has granted a data permit concerning datasets from HUS, Pirha, and Varha.
  • According to the data permit, the data processors are employees of HUS, Pirha, and Varha.
  • The data controller of the dataset is HUS, as stated in the data permit.
  • The data is processed within Findata’s secure Kapseli environment.
  • If the data processors travel to the United States for a conference:
    • An employee of HUS can process the data remotely via Kapseli from the U.S., as they are employed by the data controller.
    • Employees of Pirha and Varha, however, are not employed by the data controller (HUS), meaning they cannot process the data in Kapseli from the U.S. without a legal basis under Chapter V of the GDPR.

Under the EU’s General Data Protection Regulation (GDPR), data can be transferred within the European Economic Area (EEA) under the same conditions as within Finland. The EEA includes EU Member States, Norway, Liechtenstein, and Iceland.

For data transfers or processing outside the EEA, in so-called third countries, there must be a legal basis as outlined in Chapter V of the GDPR. The acceptable legal bases for such transfers are listed below. It is sufficient to meet just one of these bases.

Commission decision in the adequacy of data protection under Article 45
Standard contractual clauses on data protection pursuant to Article 46(2)
  • Standard contractual clauses (SCC) are standard contractual clauses approved by the European Commission that can be used in contracts between two controllers or between a controller and a processor.
  • These standard clauses can be viewed on the website of the Data Protection Ombudsman (tietosuoja.fi).
  • If this is given as the basis for data transfer, we will take this criterion into account in the data permit decision. We will make the data available outside the EU/EEA subject to this condition and only after the applicant or permit holder has submitted to Findata the signed standard contractual clauses. The use of standard clauses will also require additional examination of the adequacy of data protection.  Please note that standard contractual clauses may not be modified or added to, but must be approved as they are.
Binding corporate rules pursuant to Article 47
  • Binding corporate rules (BCR) refer to shared, binding rules for the transfer of personal data to third countries within a corporate group or group of companies engaged in joint economic operations.
  • For more information, see the website of the Data Protection Ombudsman (tietosuoja.fi).
  • If this is given as the basis for data transfer, we will take this criterion into account in the data permit decision. We will make the data available outside the EU/EEA area subject to this condition and only after the applicant or permit holder has notified the Findata of the code of conduct in question, which must have been appropriately approved by a data protection ombudsman of an EU Member State.
Exceptions and safeguards under Article 49

Exceptions and safeguards under Article 49, such as the explicit consent of the subject to the proposed transfer after being informed of the risks associated with the transfer. This basis for transfer can only be used in exceptional cases.

For information on transferring data to the United Kingdom following Brexit, visit the Data Protection Ombudsman’s website (tietosuoja.fi).

Permit fees and other costs

Fees are charged for decisions on data permit applications, data requests, and amendment applications, including the related data processing.

The costs consist of the following, depending on your application:

  • Decision fee: Charged according to the pricelist.
  • Hourly fee: For data processing carried out at Findata.
  • Data controller costs: Costs for the extraction and delivery of data, based on each controller’s provisions.
  • Kapseli fee: Costs of secure processing environment Kapseli, where individual-level data is forwarded for analysis

During the application process, we will request a maximum cost estimate from the controller for data extraction and provide a maximum cost estimate for Findata’s data processing. These estimates will be forwarded to the applicant before the permit decision is made. The final price is confirmed after the data is disclosed. A separate processing fee applies to expired and negative decisions.

For more details, visit the Pricing page.

After applying

How does Findata process applications?

  1. Applicant contacts the controllers before submitting the application
    • Contact controllers directly for additional information on data or variables.
    • Request cost estimates and feasibility details from controllers.
    • Use the extraction description form (Word document, 56 KB)
    • If you are applying for a statistical data with a data request, describe the statistics generation in the Tabulation plan (Excel file, 19,2 kB)
    • If you arrange special data extraction agreements with the controller, include this in the Additional Information section of your application.
      • For example, if a clinician from the research team will perform the extraction free of charge, include details in the Additional Information section about who agreed to this and under what conditions.
  2. Applicant submits the application to Findata
    • Submit your application or any requested additional information via our e-service (asiointi.findata.fi).
    • If only additional information is required, clarifications may be submitted by email on a case-by-case basis.
  3. Findata reviews the application and invites the applicant to a remote meeting for personal consultation
    • We review data permit approximately within a week of receipt.
    • We invite the applicant to a remote Teams meeting to discuss the content of the application and to ask clarifying questions.
    • The applicant provides more information or clarification if needed.
  4. Findata sends requests for cost estimates to data controllers
    • Findata sends requests for additional information and maximum cost estimates to the controllers, who provide the data.
    • Controllers have 15 working days to respond.
    • We will forward any additional questions from controllers to the applicant.
  5. Findata sends the cost estimates of the controllers’ extraction and Findata’s data processing to the applicant for approval
    • Once we have received the cost estimates from the data controllers, we assess the working time required for processing the data and estimate the maximum total cost.
    • We provide the cost estimates for the applicant to review and accept.
    • Note that you cannot change the extraction conditions after approval. Any modifications to the extracted data will require a new application.
  6. Findata issues a decision
    • Data permits are for a fixed period.
    • If you need to store the data for purposes such as research verification, or if you plan to renew your permit or require regular updates, include these needs in your application.

How does Findata compile the data?

  1. Findata sends data extraction requests to controllers who extract the data
    • Each controller has 30 working days to submit the requested data to Findata.
    • The extraction may involve multiple steps, such as:
      • Extraction of the target group
      • Extraction of controls
      • Extraction of additional data
    • Each step can take up to 30 working days, potentially totaling up to 90 working days.
  2. Findata pre-processes the extracted data
    • We will review, combine, and pseudonymise the data or generate statistics according to the data request.
  3. Findata delivers the data to the permit holder
    • The processed data will be provided to a secure processing environment, typically in CSV format.
    • Findata’s secure processing environment, Kapseli, is the primary option. Data may be disclosed to other environments if necessary.
    • The target time for delivering the data is 60 working days.
      • This timeframe may be extended if the target group is not provided immediately, if extraction is conducted in multiple stages, if there are delays from controllers, or if the data is particularly complex.
  4. Permit holder reviews the data
    • You have three months to review the data and notify Findata of any discrepancies or comments.
    • Thoroughly check the data, as errors can lead to additional work.
      • For example, errors that occur during extraction can accumulate, such as if the target group is formed incorrectly, requiring additional extractions from other controllers.
    • If you find omissions or errors, email Findata at data@findata.fi with detailed descriptions of how your data differs from the extraction description.
  5. Findata deletes the data from its own processing systems once the retention period has expired.
    • We remove the datasets from our systems four months after delivery.
    • We retain the code keys for pseudonymised data to allow reproduction if needed.
    • Data permits are for a fixed period.
      • If you need to save data for purposes like research verification, plan to renew the permit, or require regular updates, include these needs in your application.

Errors or omissions in data

  1. Upon receiving the data, review it as soon as possible, but no later than within three months.
  2. If you notice any omissions or errors, contact Findata at data@findata.fi.
  3. In your message, explain precisely how your data differs from the data described in the extraction description.

Data extractions under a data permit or request are always based on the extraction description. If the description you provided is incomplete, you can complete the extraction by submitting an amendment application or a new application for a data permit to Findata.

The maximum price estimates given are based on the extraction description the applicant has provided. If the extraction needs to be completed, a new maximum price estimate will be submitted with the new permit.

Where can the data be analysed?

Data analysis depends on the type of permit you have:

Data request | Aggregated statistical data

  • Statistical data is sent to the applicant and can be analysed according to the data utilisation plan.
  • Statistical data is primarily sent via the Tunneli transfer service. If you need Tunneli credentials, order them from our e-service.

Read more: Data transfers

Data permit and amendment permit | Data on individuals

  • Induvidual-level data can only be analysed in a secure environment.
  • Primarily, the data will be disclosed to Findata’s secure processing environment, Kapseli.
  • The Secondary Use Act allows for disclosure to other secure processing environments if necessary.
  • Data from controllers other than Findata will also be disclosed in a secure environment.
  • Amendment permits are considered data permits, so the same security requirements apply.

Read more: Kapseli

Findata’s regulation on secure operating environments

Findata has established a regulation in accordance with the Secondary Use Act that outlines the information security requirements for secure operating environments used by other service providers.

This regulation applies to all purposes for which a data permit is required, including:

  • Scientific research
  • Statistics
  • Education (preparation of teaching materials)
  • Planning and reporting duty of an authority

Data disclosure: Data can only be disclosed for processing in a secure environment other than Findata’s Kapseli if it meets the regulation’s requirements.

Assessment and certification: The environment must be assessed by an information security assessment body, and a certificate of assessment must be provided. These requirements have been in force since 1 May 2022.

Existing permits: The new requirements do not affect permits granted before 1 May 2022. Data can continue to be processed in the same environment under previously granted permits.

Technical solutions: Secure environments can range from physically and technically secure spaces with isolated devices to cloud-based solutions, provided they meet required data security levels. Foreign researchers must also comply with data protection and security standards.

For more details, visit the page on Regulation on Secure operating environments.

Clinically significant findings

Under Section 55 of the Secondary Use Act, a data permit holder may notify Findata of a clinically significant finding that could make it possible to prevent a health-related risk for a specific patient or to significantly improve the quality of care.

Findata forwards the information to designated experts at the Finnish Institute for Health and Welfare (THL), who assess the significance of the information and the expected benefits of any feasible actions based on it.

If the finding is considered significant and the individual could benefit from an existing treatment, THL forwards the information to the wellbeing services county responsible for the individual’s care.

An employee of the wellbeing services county will contact the individual concerned, unless the person has refused to be contacted on the basis of a clinically significant finding.

How to report a clinically significant finding to Findata
  1. Fill in the following forms:
    • Annex 1: Enter the subject’s pseudonym / personal identity code and project details on the form. Personal data will be kept separate during the process to avoid unnecessary identification of the subject and to enhance data protection.
    • Annex 2: Fill in the relevant information on the form regarding the finding and any characteristics of the subject.
    • THL experts do not have access to the patient’s health data for the purpose of making the decision, so the decision will be based on the information provided.
  2. Send an email to data@findata.fi, stating that you wish to report a significant clinical finding.
    • Do not send personal data by email!
    • Use the following subject line: Clinically significant finding.
  3. You will receive a reply message with instructions on how to deliver the information to Findata.
    • Personal data must be delivered securely via the Tunneli transfer service.
    • If you do not have Tunneli credentials, order them according to the instructions: Data transfers to Findata.
      • See the section Open the Tunneli connection.
      • In the credentials order form, enter the case number of the data permit based on which the clinically significant finding was identified (e.g.). Enter “pykälä55” in the Identifier field.
    • If you already have Tunneli credentials, we will share a Tunneli folder for you to deliver the information. Transfer the files according to the instructions: Data transfers to Findata.
      • See the section “Encrypt your data resource and transfer it to Tunneli”.
      • Once you have delivered the files, notify us by email at data@findata.fi
  4. Deliver the following documents to Findata via Tunneli:
    • Annex 1
    • Annex 2
    • Research plan and summary of the research plan (including the research group’s contact details)

The Finnish Institute for Health and Welfare (THL) will process the findings within approximately four weeks. During holiday periods, processing may take longer. The permit holder will not be automatically notified of the decision. If desired, the permit holder may request confirmation that the finding has been processed, but not information on the outcome of the decision.

Right to object:

  • Individuals can object to being contacted based on Section 55.
  • Objections can be made at any public health care unit or online via My Kanta.
  • Contact prohibitions cannot be set up through Findata, Kela, or THL.

Verifying the anonymity of results

The processor of personal data must produce results in an anonymous format that does not reveal any individual data or characteristics. Findata ensures anonymity in accordance with the Secondary Use Act for all data authorised under the Act. This process is provided at no additional cost.

For detailed criteria on ensuring anonymity and examples of common types of analysis, see the page Producing anonymous results.

Publishing results

Publication refers to making information publicly available, which includes presenting results outside your immediate working group. This can be in the form of a scientific journal, thesis, textbook, manual, conference presentation, abstract, report, survey, or internet publication.

Publishing results from Kapseli

The data is processed within the Kapseli environment, and only the final analysis results are published. The permit holder produces the results in an anonymous format, and Findata ensures compliance with the Secondary Use Act by verifying the anonymity.

  • All results produced in Kapseli must be exported from the environment using the Portti output tool. 
  • Portti is intended solely for submitting anonymous results for verification. It must never be used to transfer personal data or any other non-anonymous information. 
  • Instructions for producing anonymous results can be found on Findata’s website: https://findata.fi/en/services-and-instructions/producing-anonymous-results/  

How to publish results from Kapseli

  1. Open Portti.
    • The Portti output tool is available on the Kapseli desktop. 
  2. Select language.
    • Click ”EN” in the top right corner.
  3. Create a new transfer.
    • Click “New submission” in the top left. 
  4. Select the files to transfer.
    • Click “Choose Files” and choose the file or zip folder containing the results.
    • Only one file can be submitted at a time. If you want to transfer multiple files, compress them into a single zip folder. 
    • The maximum size for one transfer is 20 MB. 
  5. Fill in the required information.
    • Complete the requested information in the “Results to be submitted” and “Summary” sections. 
    • Select the result type(s) that best describe your results. The transfer will not proceed without this selection. You may choose multiple options.
  6. Submit the results.
    • Click “Submit.” The results will be sent to Findata for anonymity verification.

Processing transfers and approving results 

  1. Schedule and communication 
    • Findata processes the results within five business days of submission. 
    • You can track the status of your transfers in the “My submissions” view in Portti. 
    • Findata sends messages from the address: portti@csc.fi
    • When you reply to the email, your message is automatically directed to data@findata.fi, where Findata staff will read it. 
  2. If anonymity needs to be reconsidered 
    • You will receive an email detailing the required changes. 
    • Make the corrections as instructed and submit a new transfer via Portti. 
  3. Approval of results 
    • Once the results are approved, they will be transferred to the submitter’s personal Tunneli (formerly Nextcloud). You will receive an automatic email notification. 
    • Results are automatically deleted from Tunneli 6 months after the transfer, so remember to save them to your own device in time. 
  4. If additional information on anonymity is needed 
    • Findata may request more information about the anonymity of the results before final approval. 
    • After the email exchange, you will receive an official notification of either approval or rejection of the results’ anonymity.

Please note that if your result files are very large, the verification process may exceed the usual 5-day time limit.

Publishing results from other secure processing environments
  1. Verify the anonymity of results: Use guidelines on the page Procucing anonymous results
  2. Download and complete the form for verifying the anonymity of the results
  3. Compress the files and the summary form into a zip folder named as follows: Results_[Record_number_of_permit_decision][Processing_environment_ID][Delivery_date]
    • E.g.: Results_THL_1234_14.02.00_2020_a01_15032021
    • Note: Date format should be ddmmyyyy.
  4. Choose whether you will deliver the results to Findata via Tunneli or secure email
    • If you have a Tunneli (former Nextcloud) ID, transfer results via Tunneli.
    • If you do not have a Tunneli ID, transfer results via secure email.
    • Note: never send results via regular, non-secure email.
  5. Notify Findata whether you will deliver the results via Tunneli or secure email
    • Email Findata at data@findata.fi with the subject Ensuring the anonymity of results
    • Indicate whether you are using Nextcloud or secure email for the transfer.
  6. Delivering results via Tunneli
    • In the email, include the diary number of your data permit and your Tunneli ID.
    • Findata will provide the folder name for your transfer and a zip folder with the summary form.
  7. Delivering results via secure email
    • Findata will send a secure email for you to reply with your zip folder containing the results and the summary form.
  8. If there are concerns about the anonymity of the results, Findata will contact you within seven working days.
    • If you do not hear from us within this timeframe, you may proceed with publishing your results.

Note: Results exported from Statistics Finland’s Fiona remote processing environment after 18 March 2025 do not need to be submitted separately to Findata for anonymity verification.

Report published research results to Findata

Use the form below to report articles and publications that have made use of data authorised by Findata. One of the criteria for the issuing of a data permit for the purpose of scientific research is that the results are published as scientific publications. The form can also be used to report publications of data authorised for other uses.

Reference guide

If Findata has granted a data permit or made a data request decision for your project, cite Findata in publications as follows: “Sosiaali- ja terveysalan tietolupaviranomainen Findata” or “Finnish Social and Health Data Permit Authority Findata.”

  • Follow the writing guidelines of the scientific publication series.
  • We recommend that references to Findata be made in accordance with its statutory duties. In data permits, these duties include, for example, pseudonymization and ensuring the anonymity of results, and in data requests, the duties include data integration, aggregation, and anonymization.
  • Findata can be referenced in the text, tables, figures, permit lists, acknowledgments, and reference lists.
  • Whenever possible, include the diary number(s) of the data permit or data request in the references.

Examples of in-text citations

“Research data was obtained from the Finnish Social and Health Data Permit Authority Findata with data permit THL/XXXX/14.XX.00/20XX. Findata was responsible for the pseudonymization of the data and ensuring the anonymity of the final results.”

“The statistics were produced by Findata, the Finnish Social and Health Data Permit Authority, with data request THL/XXXX/14.XX.00/20XX. Findata was responsible for data integration and producing the anonymized statistics.”

Example of table citation

DataSource
Research dataFinnish Social and Health Data Permit Authority Findata, data permit THL/XXXX/14.XX.00/20XX

Example of citation in a reference list

Findata. (Year). Data permit THL/XXXX/14.XX.00/20XX. Finnish Social and Health Data Permit Authority Findata.

Published reserach results based on registry data permitted by Findata

Published research results

The table below contains information on publications that have used registry data authorised by Findata. Permit holders report their publications to Findata themselves.

Submit your publications here: Report published research results

Table updated: 18 November 2025

Year of publicationProject nameTitle of publicationAuthorsPublication channelDOI / Link to publication
2025Ulkosynnytinsyövän leikkauskäytännöt – vaikutus leikkauskomplikaatioihin ja onkologiseen ennusteeseenElectrothermal bipolar vessel sealing devices are associated with lower rates of postoperative complications compared to ultrasonic devices in vulvar cancer surgery.Mörsky MK, Kaartinen IS, Nyberg RHPLOS ONE, 20(10): e0335266https://doi.org/10.1371/journal.pone.0335266
2025Ulkosynnytinsyövän leikkauskäytännöt – vaikutus leikkauskomplikaatioihin ja onkologiseen ennusteeseenOncological outcomes, surgical margins, and adjuvant treatment delays in vulvar cancer patients with or without reconstruction during primary surgery.Mörsky MK, Nyberg RH, Vuento MH, Staff S, Kaartinen ISInternational Journal of Gynecological Cancer, 35(7):101942https://doi.org/10.1016/j.ijgc.2025.10194
2025REAL-WORLD EVIDENCE STUDY OF THE IMPACT OF ASCT AND NEW DRUG TREATMENTS ON MULTIPLE MYELOMA (MM) SURVIVAL AND COMORBIDITIES COMPARED TO non-MM CONTROL POPULATION IN FINLAND BETWEEN 2000-2020A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland.Anttalainen A, Havula E, Kysenius K, Toppila I, Miettinen T, Lassenius M, Silvennoinen R, Partanen A, Putkonen MAnnals of Hematology, 104(4):2373–2385https://doi.org/10.1007/s00277-024-06101-3
2025Long Acting Injectable Buprenorphine Use in FinlandEarly experiences of buprenorphine long-acting injection in Finland: a retrospective cohort study.Partanen M, Saarenpää T, Prami T, Iso-Mustajärvi I, Vehkala M, Landelius Torper O, Ryder B, Simojoki KPoster, International Society of Addiction Medicine (ISAM) Annual Conference, Hamburg, Germany
2025Jakavi (ruxolitinib) treatment outcomes in acute graft versus host disease (GvHD) in real-world setting in Helsinki and Turku University HospitalsRuxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland.Martelin E, Kuikka A, Rajala H, Ruohonen T, Mönkkönen H, Vikkula J, Uusi-Rauva K, Salmenniemi U, Itälä-Remes MAnnals of Hematology, 104, 3451–3458 (2025)https://doi.org/10.1007/s00277-025-06439-2
2025Multiple Myeloma (MM) – Characteristics, treatment praxis, Healthcare Resource Utilization (HCRU) and utilization of machine learning tools to identify novel risk factorsEvolution of treatment practices and outcomes in multiple myeloma during 2013–2022: a Finnish real-world registry study.Partanen A, Waltari M, Vikkula J, Mattila R, Närhi K, Eeva J, Putkonen MActa Oncologica, 64:598–606https://doi.org/10.2340/1651-226X.2025.42647
2025Burden of illness in asthma and COPDBurden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: a Finnish cohort study.Kankaanranta H, Viinanen A, Klåvus A, Lassenius MI, Olsen HH, Nieminen K, Lyly A, Kauppi P, Lehtimäki LJournal of Allergy and Clinical Immunology: Global, 4(2):100453https://doi.org/10.1016/j.jacig.2025.100453
2025Keskivaikean ja vaikean atooppisen ekseeman hoito ja dupilumabin käyttö SuomessaCharacterizing patients and treatment patterns in moderate-to-severe atopic dermatitis in Finland: a population-based study using national health data.Remitz A, Peltonen EJ, Korhonen L, Nortamo P, Iso-Mustajärvi I, Prami T, Oinonen L, Gittens B, Von Arx LB, Porsdal VActa Dermato-Venereologica, 105, adv41244https://pubmed.ncbi.nlm.nih.gov/40271985/
2025Association between dental fear and the dental attendance of the familyChanges in oral health-related quality of life according to public oral health procedures in parents of young children from the FinnBrain Birth Cohort Study.Palo K, Tolvanen M, Suominen A, Karlsson H, Karlsson L, Lahti SCommunity Dentistry and Oral Epidemiology (Wiley), 53: 382-388.https://onlinelibrary.wiley.com/doi/10.1111/cdoe.13039
2025Disease management, outcomes, and health care resource use associated with real-life clinical practice of diabetes and diabetic kidney disease in Finland (FinDIABREN-RWE)Diabeteksen munuaistaudin toteaminen on puutteellista Keusoten alueella.Laine MK, Haapala M, Uusi-Rauva K, Aakko J, Pentikäinen M, Mikkola K, Halonen N, Pulkki K, Säävuori N, Groop P-H, Metsärinne KSuomen Lääkärilehti, 80:e43390https://www.laakarilehti.fi/e43390
2025FINHRBC – epidemiology and clinical characteristics of hormone receptor positive breast cancer patients in FinlandReal-world observational study of incidence and outcomes in an HR+/HER2– early breast cancer population with high risk of recurrence in Finland.Singh, R., Tuominen, S., Lassenius, M.I. et al.Oncology and Therapy 13, 185–200 (2025)https://doi.org/10.1007/s40487-024-00324-0
2025Patient characteristics and treatment landscape of metastatic castration resistant prostate cancer in FinlandReal-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study.Rannikko A, Hölsä O, Ågesen T, Ekman M, Mattila RActa Oncologica, 64:173–178https://doi.org/10.2340/1651-226X.2025.42173
2025The SORREL study – Prevalence, Characteristics, and Burden of Nasal Polyps in Chronic Rhinosinusitis Patients in FinlandPredictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps.Toppila-Salmi S, Lyly A, Simin J, Aakko J, Haugom Olsen H, Lehtimäki LClinical and Translational Allergy, 2025;e70032https://onlinelibrary.wiley.com/doi/10.1002/clt2.70032
2025SOTE-PALVELUT LÄPINÄKYVIKSI: Palvelu- ja tietointegraatio yhtenäisen tietomallin ja yhdistetyn tietopohjan avullaChanges in depression medication following the initial assessment by specialised psychiatry services in the Helsinki-Uusimaa RegionJuntura J, Näätänen P, Joffe G, Ekelund J, Leskelä R-L, Ito T, Rive B, Godinov Y, Eriksson I, Torkki PEPA 2025 (Conference abstract)
2025Attention deficit hyperactivity disorder (ADHD) care in FinlandUse of Antidepressants Decreased After Initiation of ADHD Treatment in Adults—A Finnish Nationwide Register Study Describing Use of ADHD and Non-ADHD Medication in People With and Without ADHDWestman E, Prami T, Kallio A, Iso-Mustajärvi I, Jukka J, Raittinen P, Korhonen MJ, Puustjärvi A, Leppämäki SActa Psychiatrica Scandinavica 152, no. 3 (2025): 203–215https://doi.org/10.1111/acps.70007
2025Työkyvyn tila SuomessaTyökyvyn ja työhön osallistumisen kokonaisvaltainen tarkastelu ja palvelu- ja etuusjärjestelmän reunaehdot : Tutkimustuloksia päätöksenteon tueksiHenriksson M, Mesiäislehto M, Ahola E, Joensuu M, Kärkkäinen S, Laaksonen J, Saikku P, Siltala V, Turunen JSosiaali- ja terveysministeriön raportteja ja muistioita 2025:5http://urn.fi/URN:ISBN:978-952-00-8681-7
2025Työkyvyn tila SuomessaTutkimus: työkykyä on tuettava työelämän muutoksissa ennen kuin työkyvyttömyysriskejä ilmaantuuSosiaali- ja terveysministeriöSosiaali- ja terveysministeriöhttps://stm.fi/-/tutkimus-tyokykya-on-tuettava-tyoelaman-muutoksissa-ennen-kuin-tyokyvyttomyysriskeja-ilmaantuu
2024REAL-WORLD EVIDENCE STUDY OF THE IMPACT OF ASCT AND NEW DRUG TREATMENTS ON MULTIPLE MYELOMA (MM) SURVIVAL AND COMORBIDITIES COMPARED TO non-MM CONTROL POPULATION IN FINLAND BETWEEN 2000-2020Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021.Kysenius K, Anttalainen A, Toppila I, Miettinen T, Lassenius M, Lievonen J, Partanen A, Silvennoinen R, Putkonen MAnnals of Hematology, 103, 2931–2943 (2024)https://doi.org/10.1007/s00277-024-05865-y
2024Multiple Myeloma (MM) – Characteristics, treatment praxis, Healthcare Resource Utilization (HCRU) and utilization of machine learning tools to identify novel risk factorsA real-world study of multiple myeloma patients with at least 3 prior treatment lines and triple class exposed disease in Finland: outcomes and need for healthcare resource use.Putkonen M, Kivioja A, Vikkula J, Waltari M, Mattila R, Närhi K, Eeva J, Partanen AValue in Health, 27(12):S2https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4018/143359
2024Raskauden aikaisen metformiini-altistuksen pitkäaikaiset vaikutukset lapseen Suomessa – CLUE-tutkimusMetformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study.Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, et al.BMJ Open Diabetes Research & Care, 10(1):e002363https://drc.bmj.com/content/10/1/e002363
2024Raskauden aikaisen metformiini-altistuksen pitkäaikaiset vaikutukset lapseen Suomessa – CLUE-tutkimusMetformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study.Brand KM, Thoren R, Sõnajalg J, Boutmy E, Foch C, Schlachter J, et al.BMJ Open Diabetes Research & Care, 10(6):e003056https://drc.bmj.com/content/10/6/e003056
2024Endometrial Cancer Real World Evidence Study in Finland: A Real-World study on patient characteristics, treatment patterns and outcomes of recurrent or advanced endometrial cancer patients in FinlandHealthcare resource utilisation (HCRU) and medical costs among patients with endometrial cancer in a real-world setting in Finland (the FIRE study).Mascialino B, Aakko J, Kysenius K, Tuominen S, Idänpään-Heikkilä J, Käkelä S, Tikka S, Schneider D, Hietanen S, Lassus H, Auranen APoster, ISPOR Europe Meeting, Barcelona, Spain
2024TYÖOTE – HANKKEEN VAIKUTTAVUUSTUTKIMUS – Rekisteripohjainen arviointitutkimus vastuullisen asiakasohjausmallin etuisuusmaksu- ja tuottavuusvaikutuksistaEffectiveness of the Coordinated Return to Work model after orthopaedic surgery for lumbar discectomy and hip and knee arthroplasty: a register-based study.Lavikainen P, Heiskanen J, Jalkanen K, Lehtimäki A-V, Vehkala S, Kangas P, Husman K, Vohlonen I, Martikainen JOccupational and Environmental Medicine, 81:150–157https://doi.org/10.1136/oemed-2023-109276
2024Työkykyriskin ennustaminen ja korkeariskisten henkilöiden ryhmittely ennaltaehkäisevän työterveyshuollon tueksiAssociations of depressive symptoms and psychosocial working conditions with sickness absences in a Finnish cohort of 11,495 employees.Anttila A, Nuutinen M, Van Gils M, Pekki A, Sauni RPreventive Medicine Reports, 47https://authors.elsevier.com/sd/article/S2211-3355(24)00314-0
2024Kystisen fibroosin epidemiologia ja hoito SuomessaCystic fibrosis patient characteristics and healthcare resource utilisation in Finland using linked registries.Malmivaara K, Pölkki M, Prami T, Raittinen P, Heikkilä E, Aalto A, Dunder T, Elenius V, Sandström K, McGarry LJHeliyon, 10:e33439https://www.cell.com/action/showPdf?pii=S2405-8440%2824%2909470-2
2024Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa.Novel epigenetic biomarkers for hematopoietic cancer found in twins.Clemmensen SB, Frederiksen H, Mengel-From J, Heikkinen A, Kaprio J, Hjelmborg JVActa Oncologica, 63:710–717https://doi.org/10.2340/1651-226X.2024.40700
2024Finnish Diabetes Control study – FinDiConIncreasing clinical inertia in basal insulin initiations in people living with type 2 diabetes in Finland23rd Nordic Congress of General Practice 2024; Turku, Finland; 11–14 June 2024
2024Finnish Diabetes Control study – FinDiConTrends in demographics and diabetes-related complications in people living with type 1 diabetes between 2014 and 2021 in Finland60th Annual Meeting European Association for the Study of Diabetes; Madrid, Spain; 10–13 September 2024
2024Sähköisten reseptien hyödyt ja kustannuksetInformation Technology, Improved Access, and Use of Prescription DrugsBöckerman P, Kortelainen M, Laine LT, Nurminen M, Saxell TJournal of the European Economic Association 23(1):396–430https://doi.org/10.1093/jeea/jvae034
2024Sähköisten reseptien hyödyt ja kustannuksetAntidepressant Persistence Before and After the Introduction of Online RenewalKovalainen O-TMaster’s thesis, University of Helsinkihttps://ethesis.helsinki.fi/repository/handle/123456789/2/browse?type=author&value=Kovalainen%2C+Olli-Tuomas
2024lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusNew reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in eldersHeikkilä E, Katajamäki T, Salminen M, Irjala K, Viljanen A, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari LClinica Chimica Acta 2024;556:117844https://doi.org/10.1016/j.cca.2024.117844
2024lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusPredicting successful ageing among older adults seems possible even as far as two decades aheadViljanen A, Salminen M, Irjala K et al.BMC Geriatrics 2024;24:481https://doi.org/10.1186/s12877-024-02481-5
2024SOTE-PALVELUT LÄPINÄKYVIKSI: Palvelu- ja tietointegraatio yhtenäisen tietomallin ja yhdistetyn tietopohjan avullaSocietal costs of depression and outcomes of care in FinlandNäätänen P, Juntura J, Joffe G, Ekelund J, Nuutinen M, Leskelä R-L, Ito T, Rive B, Godinov Y, Eriksson I, Torkki PICHOM 2024 (Conference abstract)
2024Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period)Seasonality of Birth Weight in Singleton Full-term Births in FinlandOrderud H., Eskelinen N., Lindberg M.Finnish Yearbook of Population Research, 57, 21–46https://doi.org/10.23979/fypr.136379
2024Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period)Low and very low birthweight disadvantage in compulsory education achievement and transition to upper secondary educationLindberg M. Child Care Health Dev, 50(2):e13243https://doi.org/10.1111/cch.13243
2024KasvaingeenitutkimusCancer incidence following non-neoplastic medical conditionsSipilä LJ, Tanskanen T, Heikkinen S, Seppä K, Aavikko M, Ravantti J, Aaltonen LA, Pitkäniemi JActa Oncologica, 63(1), 841–849https://doi.org/10.2340/1651-226X.2024.40757
2024KasvaingeenitutkimusLynch syndrome-associated and sporadic microsatellite unstable colorectal cancersMartin S, Katainen R, Taira A, Välimäki N, Ristimäki A, Seppälä T, Renkonen-Sinisalo L, Lepistö A, Tahkola K, Mattila A, Koskensalo S, Mecklin JP, Rajamäki K, Palin K, Aaltonen LA.Human Molecular Genetics, 33(21):1858–1872https://doi.org/10.1093/hmg/ddae124
2024KasvaingeenitutkimusNon-stem cell lineages as an alternative origin of intestinal tumorigenesisVerhagen MP., Joosten R., Schmitt M., Välimäki N., ym.Nat Genet 56, 1456–1467https://doi.org/10.1038/s41588-024-01801-y
2024KasvaingeenitutkimusDetection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohortSipilä LJ ym.Familial Cancer 23, 647–652https://doi.org/10.1007/s10689-024-00400-4
2024KasvaingeenitutkimusGenome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposureSipilä LJ ym.Genes and Environ 46, 12https://doi.org/10.1186/s41021-024-00306-8
2024Trends in operative delivery rates in Estonia and Finland.Caesarean section and operative vaginal delivery in Estonia and Finland from 1992 to 2016Sildver K., Veerus P., Gissler M., Lang K., Pisarev H.European Journal of Public Health, 34(6):1205–1209https://doi.org/10.1093/eurpub/ckae162
2024Reseptien uudistaminen ja lääkehoidon seuranta – Rekisteritutkimus potilasta kohtaamatta uudistetuista lääkityksistä ja terveydenhuollon palvelujen käytöstäRegister-based study on prescription renewal without the prescriber meeting the patientRönngård-Jalkanen A., Aarnio E., Saastamoinen L., Timonen J.Basic Clin Pharmacol Toxicol, 135(3): 321-333https://doi.org/10.1111/bcpt.14049
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminen – tuloksia työikäisen väestön ryhmittelystäTurunen J, Siltala V, Henriksson M, Ahola E, Joensuu MTyöterveyslaitos, Työelämätieto-palveluhttps://www.tyoelamatieto.fi/fi/aineistot/tyokyky-ja-tyohon-osallistuminen-tuloksia-tyoikaisen-vaeston-ryhmittelysta
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystäTurunen J, Siltala V, Henriksson M, Ahola E, Joensuu MTyöterveyslaitos, Työelämätieto-palveluhttps://www.tyoelamatieto.fi/fi/analyysit/tyokyky-ja-tyohon-osallistuminen-vertailutuloksia-tyoikaisen-vaeston-ryhmittelysta
2024Työkyvyn tila SuomessaTyöikäiset ryhmiteltiin uudella tavalla – ryhmä- ja hyvinvointialuekohtaiset erot työhön osallistumisessa isojaTyöterveyslaitosTyöterveyslaitoshttps://www.ttl.fi/ajankohtaista/tiedote/tyoikaiset-ryhmiteltiin-uudella-tavalla-ryhma-ja-hyvinvointialuekohtaiset-erot-tyohon
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminenHenriksson MHVA työikäiset verkosto
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystäTurunen JKela seminaari
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminenHenriksson MKela ja TTL verkkoseminaarihttps://www.kela.fi/yhteistyokumppanit-koulutustallenteet#verkkoseminaari-1752024-kohti-yhteista-ymmarrysta-tyokyvysta-ja-sen-tukemisesta
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminenHenriksson MTHL seminaari
2024Työkyvyn tila SuomessaWork Ability and Work Participation: Findings from a Register Study on Finland’s Working-Age PopulationTurunen J, Siltala V, Henriksson M, Joensuu M, Ahola ENordic Working Life Conference, Roskilde, Denmark
2024Työkyvyn tila SuomessaFrom Work Ability to Work PotentialHenriksson M, Joensuu M, Turunen J, Ahola E, Siltala V16th ESA Conference Porto, Portugal
2024Työkyvyn tila SuomessaMielenterveys sosiaali- ja terveysalalla sekä taide-, kulttuuri- ja tapahtuma-aloillaAhola E, Ropponen ATyöterveyslaitos, Työelämätieto-palveluhttps://www.tyoelamatieto.fi/fi/aineistot/mielenterveys-sosiaali-ja-terveysalalla-seka-taide-kulttuuri-ja-tapahtuma-aloilla
2024Työkyvyn tila SuomessaSosiaali- ja terveysalalla sekä taide-, kulttuuri- ja tapahtuma-aloilla työskennelleiden mielenterveyden ja poissaolojen kehitys on vastaava kuin muilla aloillaRopponen A, Varje PTyöterveyslaitos, Työelämätieto-palveluhttps://www.tyoelamatieto.fi/fi/analyysit/sosiaali-ja-terveysalalla-seka-taide-kulttuuri-ja-tapahtuma-aloilla-tyoskennelleiden-mielenterveyden-ja-poissaolojen-kehitys-on-vastaava-kuin-muilla-aloilla
2024Työkyvyn tila SuomessaThe role of mental health related healthcare use on work participation among unemployedSalonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen T3rd International PEROSH Conference on Prolonging Working Life
2024Työkyvyn tila SuomessaThe role of mental health related healthcare use in employment and benefit use after unemployedSalonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen TEuropean Journal of Public Healthhttps://doi.org/10.1093/eurpub/ckae144.726
2024Työkyvyn tila SuomessaHyvinvointialue työhön osallistumisen ekosysteemissäHenriksson M, Joensuu M, Turunen J, Ahola E, Ervasti J, Siltala VTyöelämän tutkimuspäivät 2024
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystäTurunen J, Siltala V, Ahola E, Henriksson M, Ahtinen S, Ervasti J, Joensuu MTyöelämän tutkimuspäivät 2024
2024Työkyvyn tila SuomessaThe role of mental health related healthcare use in employment and benefit use after unemployedSalonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen TEuropean Public Health Conference
2024Työkyvyn tila SuomessaTyökyky ja työhön osallistuminen: Tuloksia ja havaintoja työkykyohjelman laajennoksen tutkimusosuudestaHenriksson M, Joensuu M, Turunen J, Ahola E, Ervasti J, Siltala VTHL seminaarihttps://innokyla.fi/sites/default/files/2024-11/Mikko%20Henriksson%20s%20pidennetty.pdf
2024Työkyvyn tila SuomessaTyöikäisten työkyky ja työhön osallistuminenHenriksson M, Siltala VTHL seminaarihttps://innokyla.fi/sites/default/files/2024-12/TTL%20webinaari%203.12.2024.pdf
2023FinMDSCharacteristics, treatment and outcomes of myelodysplastic syndrome in two Finnish hospital districts.Tuominen S, Miettinen T, Dünweber CmedRxiv 2023.10.06.23296265https://doi.org/10.1101/2023.10.06.23296265
2023Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa.The association between night shift work and breast cancer risk in the Finnish twins cohortSchernhammer E, Bogl L, Hublin C, Strohmaier S, Zebrowska M, Erber A, Haghayegh S, Papantoniou K, Ollikainen M, Kaprio JEur J Epidemiol. 38(5):533-543https://doi.org/10.1007/s10654-023-00983-9
2023Finnish Diabetes Control study – FinDiConAlle 60-vuotiaiden tyypin 2 diabeteksen hoitotasapaino on keskimääräistä huonompiVessari H, Luoto H, Aalto A, Peltonen E. J, Iso-Mustajärvi I, Raittinen P, Prami T, Saraheimo M, Valle T.T, Saukkonen TLääkärilehti 2023https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/alle-60-vuotiaiden-tyypin-2-diabeteksen-hoitotasapaino-on-keskimaaraista-huonompi/
2023Valinnanvapaus ja kilpailu julkisessa erikoissairaanhoidossaImproving Performance Through Allocation and Competition: Evidence from a Patient Choice ReformKortelainen M, Laine LT, Lavaste K, Saxell T, Siciliani LVATT Working Papers 156https://vatt.fi/julkaisu?pubid=URN%3ANBN%3Afi-fe20231003138612
2023lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusA novel easy-to-use index to predict institutionalization and death in older population – a 10-year population-based follow-up studyHeikkilä E, Salminen M, Viljanen A, Katajamäki T, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari L, Irjala KBMC Geriatrics 2023;23:80https://doi.org/10.1186/s12877-023-03760-1
2023lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusRe-examination of successful agers with lower biological than chronological age still after a 20-year follow-up periodViljanen A, Salminen M, Irjala K, Korhonen P, Vahlberg T, Viitanen M, Löppönen M, Viikari L.BMC Geriatrics 2023;23:128https://doi.org/10.1186/s12877-023-03844-y
2023Economic burden of medicines on households: De-commodification and re-commodification (DE-RE)Austerity, economic hardship and access to medications: a repeated cross-sectional population survey study, 2013–2020Aaltonen KJ Epidemiol Community Health 2023;77:160-167https://doi.org/10.1136/jech-2022-219706
2023Economic burden of medicines on households: De-commodification and re-commodification (DE-RE)Lääkkeistä tinkiminen yleistyi hallituksen kovien säästötoimien aikaanAaltonen KINVEST Bloghttps://blogit.utu.fi/invest/2023/01/31/laakkeista-tinkiminen-yleistyi-hallituksen-kovien-saastotoimien-aikaan/
2023Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period)Birth Weight, Maternal Education, and NEET Status in Young Adulthood: Evidence Using Sibling Fixed-effectsEskelinen N., Salonen L., Kotimäki S., Lindberg M., Härkönen J.INVEST Working Paper 79, SocArXivhttps://doi.org/10.31235/osf.io/epfbz
2023Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period)Low and Very Low Birthweight Disadvantage in Compulsory Education Achievement…Lindberg MINVEST Working Paper 76, SocArXivhttps://doi.org/10.31235/osf.io/dk369
2023Trends in operative delivery rates in Estonia and Finland.Cesarean section trends from 1992 to 2016 in Estonia and FinlandSildver K., Veerus P., Lang K., Pisarev H., Gissler M.Acta Obstet Gynecol Scand. 2023; 102: 1007-1013https://doi.org/10.1111/aogs.14609
2023Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin.Dementia in former amateur and professional contact sports participants: population-based cohort study, systematic review, and meta-analysisBatty GD, Frank P, Kujala UM, Sarna SJ, Valencia-Hernández CA, Kaprio JeClinicalMedicine, Volume 61, 102056https://doi.org/10.1016/j.eclinm.2023.102056
2023Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin.Suicide and depression in former contact sports participants: population-based cohort study, systematic review, and meta-analysisBatty GD, Frank P, Kujala UM, Sarna SJ, Kaprio JEClinicalMedicine, Volume 60, 102026https://doi.org/10.1016/j.eclinm.2023.102026
2022Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa.Differences in DNA Methylation-Based Age Prediction Within Twin Pairs Discordant for CancerBode HF, Heikkinen A, Lundgren S, Kaprio J, Ollikainen MTwin Res Hum Genet. 25(4-5):171-179https://doi.org/10.1017/thg.2022.32
2022Sähköisten reseptien hyödyt ja kustannuksetInformation Integration, Coordination Failures, and Quality of PrescribingBöckerman P, Laine LT, Nurminen M, Saxell TThe Journal of Human Resources (published ahead of print December 7, 2022)https://jhr.uwpress.org/content/early/2022/12/01/jhr.0921-11910R2
2022lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusCeramides and phosphatidylcholines associate with cardiovascular diseases in the elderlyKatajamäki T, Koivula M-K, Hilvo M, Lääperi M, Salminen M, Viljanen A, Heikkilä E, Löppönen M, Iso-aho R, Kivelä S-L, Jylhä A, Viikari L, Irjala K, Pulkki K, Laaksonen RClin Chem 2022.https://doi.org/10.1093/clinchem/hvac158
2022Kehitysvammaisten lääkehoito ja asumispalvelut Suomessa.Medicine use in people with intellectual disabilities: a Finnish nationwide register studyNurminen F, Rättö H, Arvio M, Teittinen A, Vesala H. T., Saastamoinen L.Journal of Intellectual Disability Research, 67: 1291–1305https://doi.org/10.1111/jir.12988
2022Uudenlaisen, systeemisen lääkehoidon persistenssi ja adherenssi keskivaikean tai vaikean läiskä- tai nivelpsoriaasin hoidossa – Rekisteripohjainen kohorttitutkimus Suomessa ja RuotsissaPersistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patientsG. Tskhvarashvili, K. Aher, I. Sveide, U. Katus, A. Westerlund, F. Hoti, C. Wennerström, F. Hassan, J. Lee, C. Hermanrud, I. Johnsson, A. Passey, R. Nissinen, S. Polesie, T. Mälkönen, L. SaarelainenJ Eur Acad Dermatol Venereol. 2025; 39(Suppl. 1): 50–64https://onlinelibrary.wiley.com/doi/10.1111/jdv.20198
2022Long Acting Injectable Buprenorphine Use in FinlandEarly experience of buprenorphine long-acting injection in Finland: a retrospective cohort study15th European Congress on Heroin Addiction, Pisa
2022Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin.Longitudinal Associations of High-Volume and Vigorous-Intensity Exercise With Hip Fracture Risk in MenKorhonen MT, Kujala UM, Kettunen J, Korhonen OV, Kaprio J, Sarna S, Törmäkangas TJ Bone Miner Res, (8):1562-1570https://doi.org/10.1002/jbmr.4624
2021lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusA practical laboratory index to predict institutionalization and mortality – an 18-year population-based follow-up studyHeikkilä E, Salminen M, Viljanen A, Katajamäki T, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari L, Irjala KBMC Geriatrics, 21, 139 (2021)https://doi.org/10.1186/s12877-021-02077-1
2021lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusSubjective and objective health predicting mortality and institutionalization: an 18-year population-based follow-up studyViljanen A, Salminen M, Irjala K, Heikkilä E, Isoaho R, Kivelä S-L, Korhonen P, Vahlberg T, Viitanen M, Wuorela M, Löppönen M, Viikari L.BMC Geriatrics 2021;21:358https://doi.org/10.1186/s12877-021-02311-w
2021lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusChronic conditions and multimorbidity associated with institutionalization among Finnish community-dwelling older peopleViljanen A, Salminen M, Irjala K, Heikkilä E, Isoaho R, Kivelä S-L, Korhonen P, Vahlberg T, Viitanen M, Wuorela M, Löppönen M, Viikari LEur Geriatr Med 2021.https://doi.org/10.1007/s41999-021-00535-y
2021Älykäs luu – Koneoppimiseen perustuva DXA-kuvien analyysi potilaiden diagnostiikassa.Detecting pathological features and predicting fracture risk from dual-energy X-ray absorptiometry images using deep learningNissinen T, Suoranta S, Saavalainen T, Sund R, Hurskainen O, Rikkonen T, Kröger H, Lähivaara T, Väänänen SPBone reports 2021 101070https://doi.org/10.1016/j.bonr.2021.101070
2020Valinnanvapaus ja kilpailu julkisessa erikoissairaanhoidossaEffects of Maternity Ward Closures on Maternal Health in FinlandHägg MUniversity of Eastern Finland, Master’s thesishttps://erepo.uef.fi/bitstream/handle/123456789/23053/urn_nbn_fi_uef-20200932.pdf
2020Sähköisten reseptien hyödyt ja kustannuksetInformation Integration, Coordination Failures, and Quality of PrescribingBöckerman P, Laine LT, Nurminen M, Saxell TVATT Working Papers 135https://vatt.fi/julkaisu?pubid=URN%3AISBN%3A978-952-274-260-5
2020lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimusFrailty, walking ability and self-rated health predicting institutionalization; an 18-year follow-up among Finnish community-dwelling older peopleViljanen A, Salminen M, Korhonen P, Irjala K, Wuorela M, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Viikari LAging Clin Exp Res 2020https://doi.org/10.1007/s40520-020-01551-x
2020Työkyvyn tila SuomessaLabor Market Participation Before and After Long-Term Part-Time Sickness Absence in Finland: A Population-Based Cohort StudyErvasti J, Kausto J, Koskinen A, Pentti J, Vahtera J, Joensuu M, Turunen J, Oksanen T, Kivimäki MJournal of Occupational and Environmental Medicinehttps://journals.lww.com/joem/fulltext/2020/04000/labor_market_participation_before_and_after.11.aspx

Frequently asked questions

How does Findata process applications?
  1. Applicant contacts the controllers before submitting the application
    • Contact controllers directly for additional information on data or variables.
    • Request cost estimates and feasibility details from controllers.
    • Use the extraction description form (Word document, 56 KB)
    • If you are applying for a statistical data with a data request, describe the statistics generation in the Tabulation plan (Excel file, 19,2 kB)
    • If you arrange special data extraction agreements with the controller, include this in the Additional Information section of your application.
      • For example, if a clinician from the research team will perform the extraction free of charge, include details in the Additional Information section about who agreed to this and under what conditions.
  2. Applicant submits the application to Findata
    • Submit your application or any requested additional information via our e-service (asiointi.findata.fi)
    • If only additional information is required, clarifications may be submitted by email on a case-by-case basis.
  3. Findata reviews the application and invites the applicant to a remote meeting for personal consultation
    • We review data permit approximately within a week of receipt.
    • We invite the applicant to a remote Teams meeting to discuss the content of the application and to ask clarifying questions.
    • The applicant provides more information or clarification if needed.
  4. Findata sends requests for cost estimates to data controllers
    • Findata sends requests for additional information and maximum cost estimates to the controllers, who provide the data.
    • Controllers have 15 working days to respond.
    • We will forward any additional questions from controllers to the applicant.
  5. Findata sends the cost estimates of the controllers’ extraction and Findata’s data processing to the applicant for approval
    • Once we have received the cost estimates from the data controllers, we assess the working time required for processing the data and estimate the maximum total cost.
    • We provide the cost estimates for the applicant to review and accept.
    • Note that you cannot change the extraction conditions after approval. Any modifications to the extracted data will require a new application.
  6. Findata issues a decision
    • Data permits are for a fixed period.
    • If you need to store the data for purposes such as research verification, or if you plan to renew your permit or require regular updates, include these needs in your application.
How does Findata compile datasets?
  1. Findata sends data extraction requests to controllers who extract the data
    • Each controller has 30 working days to submit the requested data to Findata.
    • The extraction may involve multiple steps, such as:
      • Extraction of the target group
      • Extraction of controls
      • Extraction of additional data
    • Each step can take up to 30 working days, potentially totaling up to 90 working days.
  2. Findata pre-processes the extracted data
    • We will review, combine, and pseudonymise the data or generate statistics according to the data request.
  3. Findata delivers the data to the permit holder
    • The processed data will be provided to a secure processing environment, typically in CSV format.
    • Findata’s secure processing environment, Kapseli, is the primary option. Data may be disclosed to other environments if necessary.
    • The target time for delivering the data is 60 working days.
      • This timeframe may be extended if the target group is not provided immediately, if extraction is conducted in multiple stages, if there are delays from controllers, or if the data is particularly complex.
  4. Permit holder reviews the data
    • You have three months to review the data and notify Findata of any discrepancies or comments.
    • Thoroughly check the data, as errors can lead to additional work.
      • For example, errors that occur during extraction can accumulate, such as if the target group is formed incorrectly, requiring additional extractions from other controllers.
    • If you find omissions or errors, email Findata at data@findata.fi with detailed descriptions of how your data differs from the extraction description.
  5. Findata deletes the data from its own processing systems once the retention period has expired.
    • We remove the datasets from our systems four months after delivery.
    • We retain the code keys for pseudonymised data to allow reproduction if needed.
    • Data permits are for a fixed period.
      • If you need to save data for purposes like research verification, plan to renew the permit, or require regular updates, include these needs in your application.
When do I submit an application to Findata?

Submit your data permit or amendment permit application to Findata if you want to apply for:

  • Data from several public social and health sector controllers covered by the Secondary Use Act.
  • Data from a single public controller that has transferred the right to issue permits to Findata (see the list).
  • Data from one or more private social welfare and health care service organisers.
  • Customer data saved in the Kanta Services.
  • Findata’s ready-made dataset.

If you need statistical aggregated data, send data request to Findata.

Unsure where to send your application? Use Application Assistant!

What is a data controller?

A data controller is a person or organisation that decides on the processing of personal data. They are responsible for ensuring that data processing is carried out securely and appropriately, and that the data is either destroyed or archived properly once the research is completed.

If the researcher is employed by the organisation conducting the research, that organisation acts as the data controller. However, an independent researcher or research group can act as the data controller themselves.

If multiple organisations jointly decide on the processing of personal data, they act as joint data controllers. In such cases, it is important to clearly agree on the responsibilities of each party.

Can data provided through Findata be combined with other information?

Data provided under the Secondary Use Act can be combined with other information, such as data collected by an individual themselves or data obtained with a separate permit. As a rule, the combining of data must be carried out by Findata or a statistics authority.

Read more: Combining other data with data applied from Findata

How do data controllers deliver extracted datasets to Findata?

Data controllers deliver the extracted datasets to Findata via secure Tunnel and Supertunnel transfer services.

Instructions for data controllers on delivering extracted datasets: Data transfers

Can I apply for data from Findata for my thesis?

You can apply for data from Findata for your thesis if you are working on a thesis for at least a higher university degree. In your application, please specify your educational institution, the degree being pursued, the thesis author, and the thesis supervisor.

The licence fees for theses are reduced. The reduced thesis licence fee applies when producing a single thesis. If the project produces multiple theses or other outputs unrelated to the thesis, the normal or extended licence fee will apply.

Tips for defining the extraction of textual data
  1. Consider necessity: Determine if textual data is essential for conducting your research.
    • The need for unstructured data must always be justified. Often, similar information can be extracted in a structured format.
    • We mask direct identifiers in textual data, which affects the usability of the data.
    • Processing textual data takes time and significantly increases costs.
  2. Request insights from the data controller on appropriate keywords.
    • The data controller is best positioned to assess which keywords will yield the most comprehensive results without extraneous information.
    • For example, the keyword pressure will produce all records related to pressure, such as blood pressure, eye pressure, etc. If the research focus is on blood pressure, the extracted textual data will contain a substantial amount of unnecessary information.
  3. Specify the length of the text snippet to be extracted on a variable-by-variable basis.
    • The text snippet should be as short as possible.
    • Request the data controller’s view on the length of the text to be extracted.
      • For instance, keyword +/- 50 characters.
  4. Ensure the extraction is scoped appropriately.
    • If the extraction can be limited to the information from a specific department or field of treatment instead of the entire healthcare district’s database, the amount of text to be extracted and the processing costs will be significantly lower.
How can I ensure that the contents of my application remain confidential?

Applications received by Findata are confidential, while Findata’s decisions are public. If a data controller has a statutory right to access information about the application’s contents, Findata may, on a case-by-case basis, provide the data controller with information about the data to be extracted and the formation of the target group.

What is a data utilisation or research plan?

A data utilisation plan refers to a research plan, project plan, or a similar plan.

The plan must specify:

  • the purpose of using the data as stated in the permit application,
  • the data controller and processors,
  • the legal basis for processing, and
  • essential aspects related to data protection and information security covering the entire data lifecycle (storage, disposal, or archiving of data).

The essential elements of the data utilisation plan are addressed in Findata’s application forms.

Common criteria for scientific research include, for example:

  • the research is based on an appropriate research plan,
  • the research has a responsible person or a responsible group,
  • the research participates in scientific discourse, meaning the results are intended to be published according to scientific principles, for example in scientific journals or as a thesis,
  • the research produces new knowledge or promotes public health or wellbeing,
  • the research has a research permit granted by the relevant organisation, if such a permit is required,
  • medical research has a favourable statement from an ethics committee.

An appropriate scientific research plan typically includes, for example:

  • background information,
  • definition of the information needs the research aims to address,
  • setting goals and research questions,
  • description of the required data and methods, and
  • consideration of ethical perspectives.
How to speed up the processing of your amendment application

Processing time for your application depends on several factors, including the clarity of your application, our current processing load, and response times from data controllers. To expedite the process:

  • Complete the application carefully ensuring all sections are filled out thoroughly and accurately.
  • Attach all previous permit decisions to your application.
  • Attach to your application all previous non-disclosure agreements (NDA). Each person handling the material to be added must have their own NDA.
  • Use Findata’s advisory service for additional support and clarification.

For more information, visit the Data page or check the Data Resources Catalogue (aineistokatalogi.fi).

What is the EHDS?

The European Health Data Space (EHDS) is a regulation of the European Union that establishes a common framework for the use and exchange of health data in EU countries. The aim of the regulation is to strengthen citizens’ rights to their own electronic health data and to enable the secure cross-border secondary use of health data.

The EHDS regulation is similar to the current Finnish Secondary Use Act, but it also introduces changes. The regulation includes partly different purposes of use, some of which are reserved only for public or EU entities. In addition, new operating models will be introduced for processing data requests and permit applications.

The regulation entered into force in March 2025 and will be implemented gradually over the coming years. The parts concerning secondary use will begin to apply in March 2029.

What are personal data?

Personal data are pieces of information that can be used to identify an individual either directly or indirectly.

Examples of personal data that allow direct identification include:

  • name,
  • personal identity code,
  • email address based on the person’s name, and
  • biometric identifiers such as fingerprints, facial images, voice, and iris patterns.

Examples of personal data that allow indirect or partial identification include:

  • gender,
  • age,
  • education, and
  • nationality.

Indirect or partial identifiers can also be combined to identify a person. Therefore, removing or replacing direct personal identifiers does not necessarily mean that the data no longer contains personal data.

Special categories (or sensitive) personal data include, for example:

  • ethnic origin,
  • sexual orientation or behaviour,
  • health data,
  • biometric data, and
  • genetic data.

Highly protected personal data include, for example:

  • psychiatric data,
  • social welfare data, and
  • data related to sexually transmitted diseases and medical genetics.
How does the data controller provide the extracted data to Findata?

For instructions on how data controllers can submit extracted data, see the Data transfers to Findata -page.

What is anonymisation and pseudonymisation?

Anonymisation means the transformation of personal data into a form that irreversibly prevents the identification of an individual person. This may mean, for example, removing direct identifiers and simplifying the data to a general level so that personal data cannot be reconstituted in any way.

Pseudonymisation refers to the transformation of personal data, for example into a coded form. In this case, names and personal identifiers can be removed and replaced by another unique identifier, i.e. a code. Often a code key is kept to restore direct personal data to the data. Pseudonymised data are still personal data.

Can I collect the data myself from my own hospital and thus avoid the data controller’s collection fee?

Yes, you can, if this is okay with the controller. The controller has the right to determine independently the manner in which it carries out the extraction, and it has the right to use an external processor to carry out the data extraction.

If such processors are used, the EU General Data Protection Regulation (GDPR) requires that a data protection agreement (DPA) covering the processing of personal data is signed with them. The controller is ultimately responsible for ensuring that the personal data is processed in a legal manner. The processor, meanwhile, is responsible for ensuring that it complies with the terms of the DPA and the instructions of the controller.

The collected data must be delivered to Findata securely via the transfer service Tunneli, after which we combine and pre-process them.

How can I modify an application I have sent?

Unfortunately, you cannot yourself modify an application after it has sent.

If you want to supplement an application that has already been sent, send us an email to info@findata.fi and tell us your application’s ID (e.g. 2022/53). We will return the application so you can supplement it.

How to speed up the processing of your application

The processing time for applications depends on several factors: the accuracy of the data extraction description, the current backlog at Findata, and the response times of data controllers.

By following the following guidelines, you can help ensure that your application is processed as quickly and efficiently as possible.

  1. Verify Findata’s authority:
    • Ensure Findata is the competent authority to issue a permit for the data you need.
    • Use the application assistant to help determine this.
    • Note that the Digital and Population Data Services Agency, the Finnish Centre for Pensions, and Statistics Finland handle their own data and permit decisions. If you need information from these controllers, contact them directly.
  2. Consult Findata’s help desk:
    • If unsure about where to send your application, contact Findata’s help desk service at info@findata.fi before submitting it.
  3. Contact data controllers directly:
    • If you need more information about the data or variables, contact the relevant data controllers. Data controllers provide advisory services for their data and can guide you on data extraction methods. You can also make an agreement on the implementation of data extraction in a certain manner with the controller.
    • In your application, mention the contact person with whom you have discussed the data extraction.
    • See information and contact details for controllers: Links to data controllers’ websites and data descriptions
  4. Use the Data Resources Catalogue:
  5. Describe your information needs accurately:
  6. Apply the GDPR minimisation principle:
    • Only request data that is essential for your purposes. The principle of minimisation as defined in the GDPR will be applied, meaning that only necessary data will be disclosed.
  7. Complete the application carefully:
    • Pay attention to entering basic data such as the applicant’s details, the data controller, invoicing details, and any other data to be combined.

Apply for a data permit

Do you need data on individuals? Apply for a data permit when you need data on individuals from multiple public sector social and health controllers or the private sector. Data permits Apply for a data permit

Submit a data request

Do you need anonymous statistical data? Submit a data request to use, when you need aggregated statistical data in table format or key figures from a social and health sector controller. Data requests Submit a data request

Apply for an amendment permit

Is your permit period about to expire or have there been changes to the processors of personal data? Apply for an amendment permit from us when an amendment concerns a controller’s permits or information. Amendment permits Apply for an amendment permit

Check the correct address for the application

Vinkkeli – AI Assistant

Select the controllers from which the data will be retrieved

Apply permit from the controller in question. The exception is those controllers who have delegated permit jurisdiction to Findata.

Please note that Findata is responsible for data permit and amendment applications whenever the data of data controllers covered by the Act on secondary use is combined. When evaluating the competent authority, all data related to the application under the Act must be taken into account.

Apply permit (s) from the controllers in question.

Findata is responsible for data permits of the Finnish Center for Pensions (ETK) and the Finnish Digital Agency (DVV) and / or Statistics Finland if the data are combined with

  • data of other public organizations under the Act on Secondary Use of Health and Social Data (For Statistics Finland, at least two other organizations are needed, for DVV and ETK, one is sufficient)
  • data stored on Kanta services or
  • to the register data of a private social or health care service provider.

Apply permit from Findata.

Findata is responsible for processing and making decisions concerning data permit and amendment applications, when the application applies to:

  • data from numerous public social and health sector controllers
  • register data from one or numerous private social welfare and health care service organisers, or
  • customer data saved in the Kanta Services.

Apply permit from Findata.

The Regional Administrative Agencies (AVI) have delegated the jurisdiction to Findata.

Apply permit from Findata.

National Supervisory Authority for Welfare and Health Valvira have delegated the jurisdiction to Findata.

Apply for a data permit

Finnish Institute for Health and Welfare (THL) has delegated the jurisdiction to Findata. As far as THL is concerned, the delegation of jurisdiction does not apply to its

  • internal permit management
  • the transfer of samples and data transferred to THL Biobank.

Permit is applied from Statistics Finland and the respective data controller. Exceptions are the registrars who have delegated the jurisdiction to Findata.

We are responsible for data permits for data subject to the Secondary Act of Statistics Finland when they are combined

  • to the information of at least two public organizations covered by secondary laws
  • to data stored in Kanta services or
  • to the register data of a private social or healthcare service organizer.

Apply permit from Findata.

Findata is responsible for processing and making decisions concerning data permit and amendment applications, when the application applies to:

  • data from numerous public social and health sector controllers
  • register data from one or numerous private social welfare and health care service organisers, or
  • customer data saved in the Kanta Services.

Please select at least one data controller or group.